Making Babies with 3 Genetic Parents Gets FDA Hearing A reproductive technology that taps three parents’ DNA as a way to eliminate hereditary diseases could reach clinical trials if the Food and Drug Administration gives the go-ahead. Reproductive technologies that marry DNA from three individuals will receive a trial in the court of public opinion this week. Such technologies may hold promise for averting certain genetically inherited diseases passed down via mutations to mitochondria, the cell’s battery pack. Scientists have already had successes with this type of reproductive approach in monkeys and in human embryos, and are now eager to...